Women’s Health

Women’s Health Pharma Company ObsEva Sells Regional Rights to Its Uterine Fibroid Drug Linzagolix to Theramex

Women’s health pharma company Theramex and ObsEva, a biopharma company developing and commercializing novel therapies for women’s health have entered into a licensing agreement to commercialize and launch Linzagolix, an oral GnRH antagonist. The launch will be for global markets outside of the U.S., Canada, and Asia. Linzagolix is a GnRH receptor antagonist for the treatment of uterine fibroids. Linzagolix is also…

FemTec Health Launches Its DTC Brand Awesome Woman to Personalize and Transform the Healthcare Experience for Women

A couple of months ago FemTec Health first made the news, when it came out of stealth with a big vision for the future of women’s health, more than $38M in fresh funding and a leadership team of industry veterans that includes Livongo co-founder Dr. Kimon Angelides, Dr. Kimberly Capone, previously Head of Microbiome Platform at Johnson & Johnson, and Dr. Laura…

HerMD Adds $10M in Series A Funding to Scale Its Physical Clinics and Launch Virtual Services Throughout the U.S.

HerMD, a company that currently operates two insurance-based, women’s health focused health care centers in Ohio and Kentucky in the U.S., has raised $10M in Series A funding from JAZZ Ventures. The new funds will be used to open additional locations, but also to enter the virtual care market and scale nation-wide. HerMD was founded in 2015 and has, according to the…

Bellabeat Seeks FDA Approval for Its Ivy Health Tracker

2021 was an exciting year at Bellabeat. About a year ago the company first launched the pre-sale for Ivy, the newest addition to its family of health trackers and successor to Bellabeat’s Leaf, which according to the company had sold more than 2.2 million times at the time of the announcement. Last fall Ivy finally started to ship receiving somewhat mixed reviews…

These Two Women’s Health Projects Received Spark Grant Innovation Awards from Ariadne Labs

Ariadne Labs has announced nine recipients of the Ariadne Labs Spark Grant innovation awards. The Spark Grant program provides support for new and early-stage ideas focused on addressing gaps in health care and improving delivery of care. This year two women’s health focused projects were among the recipients. Five projects funded by Harvard Medical School (HMS) Dean’s Innovation Grants in Health Care Delivery were…

Fertility Focus, the Company Behind OvuSense, Rebrands to viO HealthTech and Expands Its Focus Beyond Reproductive Health

Fertility Focus, the company known for its “family of fertility trackers” that includes OvuSense and OvuCore, is rebranding to viO HealthTech. And it’s not just a name change. Based on the insights gained from 210,000+ tracked cycles, the company is expanding its offering to address women’s health more holistically beyond fertility and moving into Digital Therapeutics (DTx). Over the past years the…

Nurx and Thirty Madison Are Merging with Ambitious Plans to Become the Go-To Destination for Virtual Specialty Care

And the M&A news keep coming this week… 👀 After CooperCompanies’ announced its planned acquisition of Cook Medical’s Reproductive Health business, Thirty Madison is now announcing a merger with Nurx, the company known for birth control pill delivery capabilities, that has been slowly expanding its services beyond telehealth & online pharmacy services over the past years. As for us: We’re adding yet…

Women’s Health Medtech Company Hologic Launches Its First Consumer Campaign Featuring Mary J. Blige

Women’s health medtech company Hologic is launching its first ever consumer advertising campaign this month. The campaign will launch with a 30-second spot that features none other than *the* Mary J. Blige on NBC during the “Big Game” on February 13 and run through the Winter Olympics across NBCU television and digital channels. The campaign titled “Her Health is Her Wealth” comes…